These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35999370)

  • 21. Resection after preoperative chemotherapy versus synchronous liver resection of colorectal cancer liver metastases: A propensity score matching analysis.
    Kim CW; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim TW; Kim JC
    Medicine (Baltimore); 2017 Feb; 96(7):e6174. PubMed ID: 28207557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
    Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
    Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laparoscopic vs open liver resection for metastatic colorectal cancer: analysis of surgical margin status and survival.
    Nicolás M; Czerwonko M; Ardiles V; Sánchez Claria R; Mazza O; de Santibañes E; Pekolj J; de Santibañes M
    Langenbecks Arch Surg; 2022 May; 407(3):1113-1119. PubMed ID: 34988643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study.
    Song KD; Lim HK; Rhim H; Lee MW; Kim YS; Lee WJ; Paik YH; Gwak GY; Kim JM; Kwon CH; Joh JW
    Radiology; 2015 May; 275(2):599-608. PubMed ID: 25559235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases-a Japanese Nationwide Survey.
    Kobayashi S; Beppu T; Honda G; Yamamoto M; Takahashi K; Endo I; Hasegawa K; Kotake K; Itabashi M; Hashiguchi Y; Kotera Y; Sakamoto K; Yamaguchi T; Morita S; Tabuchi K; Miyazaki M; Sugihara K
    J Gastrointest Surg; 2020 Jun; 24(6):1244-1260. PubMed ID: 31197683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
    Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
    Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined hepatic resection and ablation for high burden of colorectal liver metastases demonstrates safety and durable survival.
    Wach MM; Washburn LA; Alvikas J; Qu LT; Zhang M; Etherington MS; Rieser C; Haykal T; Pingpank JF; Zureikat AH; Geller DA; Hoehn RS; Tohme S
    HPB (Oxford); 2024 Mar; 26(3):362-369. PubMed ID: 38008683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.
    Le Roux F; Rebibo L; Cosse C; Chatelain D; Nguyen-Khac E; Badaoui R; Regimbeau JM
    J Laparoendosc Adv Surg Tech A; 2018 May; 28(5):553-561. PubMed ID: 29350570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 30. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases.
    He N; Jin QN; Wang D; Yang YM; Liu YL; Wang GB; Tao KX
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):514-518. PubMed ID: 27465325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propensity score-matched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases.
    Welsh FK; Chandrakumaran K; John TG; Cresswell AB; Rees M
    Br J Surg; 2016 Apr; 103(5):600-6. PubMed ID: 26864820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective multicentre trial on survival after Microwave Ablation VErsus Resection for Resectable Colorectal liver metastases (MAVERRIC).
    Tinguely P; Ruiter SJS; Engstrand J; de Haas RJ; Nilsson H; Candinas D; de Jong KP; Freedman J
    Eur J Cancer; 2023 Jul; 187():65-76. PubMed ID: 37119639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    Hof J; Joosten HJ; Havenga K; de Jong KP
    PLoS One; 2018; 13(3):e0193385. PubMed ID: 29543821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
    Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of type and severity of postoperative complications on long-term outcomes after colorectal liver metastases resection.
    Fernández-Moreno MC; Dorcaratto D; Garcés-Albir M; Muñoz E; Arvizu R; Ortega J; Sabater L
    J Surg Oncol; 2020 Aug; 122(2):212-225. PubMed ID: 32335938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The timing of liver resection in patients with colorectal cancer and synchronous liver metastases: a population-based study of current practice and survival.
    Vallance AE; van der Meulen J; Kuryba A; Charman SC; Botterill ID; Prasad KR; Hill J; Jayne DG; Walker K
    Colorectal Dis; 2018 Jun; 20(6):486-495. PubMed ID: 29338108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
    Huiskens J; Olthof PB; van der Stok EP; Bais T; van Lienden KP; Moelker A; Krumeich J; Roumen RM; Grünhagen DJ; Punt CJA; van Amerongen M; de Wilt JHW; Verhoef C; Van Gulik TM
    Eur J Surg Oncol; 2018 Jan; 44(1):108-114. PubMed ID: 29126672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
    Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
    Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of ultrasound-guided percutaneous microwave ablation versus resection for colorectal cancer liver metastases: a propensity-score matched study.
    Huang Z; Pan Y; Zhou P; Li S; Li K
    Int J Hyperthermia; 2021; 38(1):1276-1284. PubMed ID: 34423716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
    Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
    World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.